Progress Nears in Developing Drug to Reduce Artery-Clogging Particle
Researchers are nearing the completion of clinical trials for five experimental drugs aimed at lowering lipoprotein(a), a genetic particle linked to artery clogging and heart disease, with results expected in 2026. These drugs could significantly impact the treatment of a condition affecting about 20% of the global population, though cost and public awareness remain challenges.
